NEW YORK (GenomeWeb) – Researchers at Stanford University and the Massachusetts Institute of Technology used a combination of tumor barcoding, CRISPR-Cas9-mediated genome editing, and ultra-deep barcode sequencing to interrogate pairwise combinations of mutations in tumor suppressor genes in autochthonous mouse models of human lung adenocarcinoma in order to determine the functional impact of these alterations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.